INKON Research Development vs Income Tax Expense Analysis

300143 Stock

9.76 0.37 3.65%

INKON Life financial indicator trend analysis is infinitely more than just investigating INKON Life Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether INKON Life Technology is a good investment. Please check the relationship between INKON Life Research Development and its Income Tax Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in INKON Life Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Income Tax Expense

Research Development vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of INKON Life Technology Research Development account and Income Tax Expense. At this time, the significance of the direction appears to have strong relationship.

The correlation between INKON Life's Research Development and Income Tax Expense is 0.6. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of INKON Life Technology, assuming nothing else is changed. The correlation between historical values of INKON Life's Research Development and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of INKON Life Technology are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Research Development i.e., INKON Life's Research Development and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.6

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Research Development

Income Tax Expense

Most indicators from INKON Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into INKON Life Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in INKON Life Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of December 14, 2024, Selling General Administrative is expected to decline to about 52.6 M. In addition to that, Tax Provision is expected to decline to about 31.8 M

	2021	2022	2023	2024 (projected)
Operating Income	76.5M	119.4M	166.4M	174.7M
Total Revenue	1.1B	1.2B	1.5B	1.5B

Operating Income Total Revenue

INKON Life fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Good Will	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.51	0.41	0.95	0.14	-0.41	0.33	0.56	0.69	0.53	0.7	0.38	0.29	0.45	0.62	0.69	-0.49	0.41	0.38	0.84	0.87	-0.41	0.58	-0.85	0.66	-0.71
Other Current Liab	0.51		0.07	0.54	-0.07	-0.02	-0.04	0.54	0.3	0.21	0.13	-0.21	0.2	0.01	-0.03	0.21	-0.25	0.36	0.24	0.32	0.36	-0.16	0.42	-0.37	0.29	-0.25
Total Current Liabilities	0.41	0.07		0.2	0.2	-0.94	0.9	0.55	0.38	-0.3	0.83	0.87	0.06	0.95	0.84	0.81	-0.17	0.4	-0.43	0.62	0.56	0.05	0.55	-0.55	-0.02	-0.57
Total Stockholder Equity	0.95	0.54	0.2		0.1	-0.18	0.11	0.47	0.58	0.62	0.56	0.21	0.36	0.21	0.47	0.53	-0.53	0.4	0.51	0.73	0.78	-0.49	0.53	-0.79	0.68	-0.6
Other Liab	0.14	-0.07	0.2	0.1		-0.11	0.19	-0.01	-0.04	-0.26	0.12	0.22	-0.23	0.18	0.24	0.05	0.5	-0.08	-0.12	-0.17	-0.21	0.3	-0.18	0.25	-0.11	0.08
Retained Earnings	-0.41	-0.02	-0.94	-0.18	-0.11		-0.9	-0.6	-0.52	0.32	-0.85	-0.89	0.08	-0.9	-0.82	-0.84	0.22	-0.36	0.45	-0.69	-0.61	0.03	-0.51	0.55	-0.01	0.67
Accounts Payable	0.33	-0.04	0.9	0.11	0.19	-0.9		0.51	0.5	-0.3	0.71	0.82	-0.18	0.89	0.7	0.79	0.08	0.34	-0.39	0.6	0.48	0.13	0.43	-0.42	0.01	-0.6
Cash	0.56	0.54	0.55	0.47	-0.01	-0.6	0.51		0.62	-0.23	0.58	0.48	-0.01	0.42	0.44	0.67	-0.3	0.6	-0.21	0.66	0.6	0.01	0.65	-0.53	0.17	-0.58
Other Assets	0.69	0.3	0.38	0.58	-0.04	-0.52	0.5	0.62		0.18	0.54	0.38	-0.34	0.47	0.47	0.76	-0.31	0.11	0.32	0.82	0.78	-0.09	0.24	-0.62	0.72	-0.93
Long Term Debt	0.53	0.21	-0.3	0.62	-0.26	0.32	-0.3	-0.23	0.18		0.01	-0.27	0.44	-0.17	0.0	-0.02	-0.37	-0.03	0.75	0.29	0.42	-0.58	0.09	-0.48	0.63	-0.18
Net Receivables	0.7	0.13	0.83	0.56	0.12	-0.85	0.71	0.58	0.54	0.01		0.78	0.23	0.8	0.88	0.9	-0.49	0.5	-0.21	0.85	0.8	-0.21	0.7	-0.8	0.19	-0.71
Inventory	0.38	-0.21	0.87	0.21	0.22	-0.89	0.82	0.48	0.38	-0.27	0.78		0.02	0.81	0.85	0.73	-0.15	0.38	-0.41	0.59	0.53	-0.18	0.48	-0.51	-0.01	-0.55
Other Current Assets	0.29	0.2	0.06	0.36	-0.23	0.08	-0.18	-0.01	-0.34	0.44	0.23	0.02		-0.05	0.07	-0.06	-0.39	0.58	-0.09	0.16	0.26	-0.43	0.65	-0.46	-0.18	0.24
Total Liab	0.45	0.01	0.95	0.21	0.18	-0.9	0.89	0.42	0.47	-0.17	0.8	0.81	-0.05		0.84	0.86	-0.14	0.19	-0.25	0.66	0.6	0.04	0.4	-0.55	0.15	-0.66
Intangible Assets	0.62	-0.03	0.84	0.47	0.24	-0.82	0.7	0.44	0.47	0.0	0.88	0.85	0.07	0.84		0.82	-0.45	0.29	-0.09	0.72	0.7	-0.17	0.45	-0.67	0.3	-0.69
Common Stock	0.69	0.21	0.81	0.53	0.05	-0.84	0.79	0.67	0.76	-0.02	0.9	0.73	-0.06	0.86	0.82		-0.39	0.31	-0.03	0.9	0.83	-0.12	0.54	-0.76	0.42	-0.89
Property Plant Equipment	-0.49	-0.25	-0.17	-0.53	0.5	0.22	0.08	-0.3	-0.31	-0.37	-0.49	-0.15	-0.39	-0.14	-0.45	-0.39		-0.29	-0.26	-0.6	-0.66	0.44	-0.46	0.7	-0.42	0.47
Net Tangible Assets	0.41	0.36	0.4	0.4	-0.08	-0.36	0.34	0.6	0.11	-0.03	0.5	0.38	0.58	0.19	0.29	0.31	-0.29		-0.39	0.45	0.4	-0.13	0.93	-0.49	-0.22	-0.11
Good Will	0.38	0.24	-0.43	0.51	-0.12	0.45	-0.39	-0.21	0.32	0.75	-0.21	-0.41	-0.09	-0.25	-0.09	-0.03	-0.26	-0.39		0.15	0.25	-0.32	-0.31	-0.21	0.86	-0.29
Deferred Long Term Liab	0.84	0.32	0.62	0.73	-0.17	-0.69	0.6	0.66	0.82	0.29	0.85	0.59	0.16	0.66	0.72	0.9	-0.6	0.45	0.15		0.97	-0.32	0.67	-0.93	0.57	-0.9
Long Term Investments	0.87	0.36	0.56	0.78	-0.21	-0.61	0.48	0.6	0.78	0.42	0.8	0.53	0.26	0.6	0.7	0.83	-0.66	0.4	0.25	0.97		-0.43	0.64	-0.97	0.63	-0.87
Short Long Term Debt	-0.41	-0.16	0.05	-0.49	0.3	0.03	0.13	0.01	-0.09	-0.58	-0.21	-0.18	-0.43	0.04	-0.17	-0.12	0.44	-0.13	-0.32	-0.32	-0.43		-0.27	0.52	-0.29	0.23
Total Current Assets	0.58	0.42	0.55	0.53	-0.18	-0.51	0.43	0.65	0.24	0.09	0.7	0.48	0.65	0.4	0.45	0.54	-0.46	0.93	-0.31	0.67	0.64	-0.27		-0.73	-0.06	-0.32
Short Term Debt	-0.85	-0.37	-0.55	-0.79	0.25	0.55	-0.42	-0.53	-0.62	-0.48	-0.8	-0.51	-0.46	-0.55	-0.67	-0.76	0.7	-0.49	-0.21	-0.93	-0.97	0.52	-0.73		-0.53	0.75
Non Current Assets Total	0.66	0.29	-0.02	0.68	-0.11	-0.01	0.01	0.17	0.72	0.63	0.19	-0.01	-0.18	0.15	0.3	0.42	-0.42	-0.22	0.86	0.57	0.63	-0.29	-0.06	-0.53		-0.71
Non Currrent Assets Other	-0.71	-0.25	-0.57	-0.6	0.08	0.67	-0.6	-0.58	-0.93	-0.18	-0.71	-0.55	0.24	-0.66	-0.69	-0.89	0.47	-0.11	-0.29	-0.9	-0.87	0.23	-0.32	0.75	-0.71

Click cells to compare fundamentals

INKON Life Account Relationship Matchups

INKON Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0B	2.7B	2.5B	2.0B	2.4B	1.7B
Other Current Liab	39.1M	128.2M	288.3M	3.9M	1.7M	1.6M
Total Current Liabilities	322.8M	284.8M	555.9M	589.2M	759.4M	797.4M
Total Stockholder Equity	1.3B	2.2B	1.8B	1.3B	1.4B	1.3B
Other Liab	18.4M	16.8M	19.0M	19.3M	22.2M	21.4M
Retained Earnings	(814.3M)	(644.0M)	(1.0B)	(1.6B)	(1.5B)	(1.4B)
Accounts Payable	80.8M	120.9M	107.2M	147.8M	169.4M	177.9M
Cash	96.6M	483.6M	661.6M	433.2M	480.5M	252.3M
Other Assets	98.1M	124.1M	101.5M	93.1M	107.0M	54.4M
Net Receivables	191.9M	204.4M	155.0M	228.4M	254.4M	267.2M
Inventory	30.5M	37.7M	38.7M	106.5M	87.8M	92.2M
Other Current Assets	26.5M	22.2M	25.9M	6.2M	58.1M	51.2M
Total Liab	589.7M	410.1M	667.6M	710.5M	971.4M	1.0B
Intangible Assets	106.4M	98.0M	100.5M	198.8M	240.1M	252.1M
Common Stock	288.4M	546.8M	545.9M	642.2M	738.5M	775.4M
Property Plant Equipment	197.0M	182.4M	268.4M	288.4M	259.6M	258.8M
Net Tangible Assets	18.1M	70.4M	1.0B	651.9M	749.6M	578.1M
Good Will	1.2B	1.1B	1.0B	583.2M	693.3M	907.1M
Deferred Long Term Liab	74.9M	97.9M	76.5M	81.4M	93.6M	75.3M
Total Current Assets	345.5M	1.1B	897.9M	805.1M	912.0M	784.7M
Non Current Assets Total	1.6B	1.6B	1.6B	1.2B	1.5B	1.3B
Non Currrent Assets Other	14.5M	5.7M	15.4M	3.0M	14.6M	13.9M
Non Current Liabilities Total	266.8M	209.5M	111.6M	121.3M	212.0M	182.2M
Other Stockholder Equity	1.1M	1.7M	460.8K	(6.4K)	(7.4K)	(7.0K)
Net Invested Capital	1.7B	2.4B	1.9B	1.3B	1.6B	1.6B
Net Working Capital	22.6M	820.4M	342.0M	215.9M	152.6M	291.1M
Non Current Liabilities Other	250M	700K	780K	5.9M	43.9M	86.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in INKON Stock

Balance Sheet is a snapshot of the financial position of INKON Life Technology at a specified time, usually calculated after every quarter, six months, or one year. INKON Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of INKON Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which INKON currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

INKON Research Development vs Income Tax Expense Analysis

Research Development vs Income Tax Expense

Research Development vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Research Development

Income Tax Expense

INKON Life fundamental ratios Correlations

INKON Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

INKON Life fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in INKON Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Investments	+ 0.97	Deferred Long Term Liab
Total Stockholder Equity	+ 0.95	Total Assets
Total Liab	+ 0.95	Total Current Liabilities
Total Current Assets	+ 0.93	Net Tangible Assets
Accounts Payable	+ 0.9	Total Current Liabilities
Common Stock	+ 0.9	Net Receivables

Short Term Debt	- 0.97	Long Term Investments
Retained Earnings	- 0.94	Total Current Liabilities
Short Term Debt	- 0.93	Deferred Long Term Liab
Non Currrent Assets Other	- 0.93	Other Assets
Non Currrent Assets Other	- 0.9	Deferred Long Term Liab
Total Liab	- 0.9	Retained Earnings